Dr Reddy’s Laboratories has said that the US health regulator has concluded the audit of its API Cuernavaca Plant in Mexico.

Dr Reddy’s Laboratories (DRL) has said in a BSE filing that “The audit of our API Cuernavaca plant in Mexico by the USFDA has been completed with zero observations.”

Read EquityPandit’s Technical Analysis on Nifty Pharma